Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 11: Cost-utility analysis – Part 4.

Slides:



Advertisements
Similar presentations
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlikeLicense. Your use of this material constitutes acceptance of that license.
Advertisements

Elicitation methods Health care demands exceed resource supply Therefore, rationing is inevitable Many ways by which we can ration health care One is economic.
Measuring outcomes Emma Frew October Measuring outcomes Learning objectives By the end of the session students should be able to – Explain how different.
Emma Frew Introduction to health economics, MSc HEHP, October 2012 Outcomes: part II.
1 The Future of Quality of Life Assessment in Cost-Effectiveness Research Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy.
DEVELOPMENT OF A PREFERENCE-BASED, CONDITION SPECIFIC PATIENT REPORTED OUTCOME MEASURE FOR USE WITH VENOUS ULCERATION Simon Palfreyman 1, John E Brazier.
Decision Analysis. What is decision analysis? Based on expected utility theory Based on expected utility theory Used in conditions of uncertainty Used.
1 Does it make a difference for the patient? Survival & Quality of life  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and.
Using a discrete choice experiment with duration to estimate values for health states on the QALY scale Nick Bansback Assistant Professor School of Population.
Utility Assessment HINF Medical Methodologies Session 4.
1 Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren
A METHODOLOGY FOR MEASURING THE COST- UTILITY OF EARLY CHILDHOOD DEVELOPMENTAL INTERVENTIONS Quality of improved life opportunities (QILO)
Valuing Health Daniel M. Hausman University of Wisconsin-Madison October 19, 2009.
Valuing the SF-6D: a nonparametric approach using individual level preference data Part 1): The SF-6D and its valuation Samer A Kharroubi, Tony O’Hagan,
1 EuroQol EQ-5D Jan J. V. Busschbach, Ph.D Psychotherapeutic Centrum ‘De Viersprong’, Halsteren Department of Medical.
1 Health-Related Quality of Life Ron D. Hays, Ph.D. - UCLA Department of Medicine: Division of General Internal Medicine.
Measuring and valuing health outcome Montarat Thavorncharoensap, Ph.D. 1: Faculty of Pharmacy, Mahidol University 2. HITAP, Thailand.
MAPPING THE DIABETES HEALTH PROFILE (DHP-18) ONTO THE EQ-5D AND SF-6D GENERIC PREFERENCE BASED MEASURES OF HEALTH Brendan Mulhern 1, Keith Meadows 2, Donna.
1 EQ-5D, HUI and SF-36 Of the shelf instruments…..
Introduction to Effectiveness, Patient Preferences and Utilities Patsi Sinnott, PT, PhD, MPH HERC Economics Course May 6, 2009.
1 Health Economics  Comparing different allocations  Should we spent our money on Wheel chairs Screening for cancer  Comparing costs  Comparing outcome.
Keele Assessment of Participation (KAP): A new instrument for measuring participation restriction in population surveys Ross Wilkie, George Peat, Elaine.
Overview of the EQ-5D Purpose and origins of the descriptive system.
1 The valuation of disease-specific questionnaires for QALY analysis  To rescue data in absence of an utility measure  Growth hormone deficiency in adults.
Summary of measures of population Health Farid Najafi MD PhD School of Population Health Kermanshah University of Medical Sciences.
How can societal concerns for fairness be integrated in economic evaluations of health programs? Erik Nord, PhD, Senior Researcher, Norwegian Institute.
Selection of a Survey Instrument for a Heart Failure Disease Management Study Lee R. Goldberg, MD, MPH Heart Failure/Transplant program University of Pennsylvania.
Measuring Health Outcomes
Why use the EQ-5D? What are the alternatives?. What are the alternatives for Direct valuation? Other VAS Time Trade-Off Standard Gamble Willingness to.
IN THE NAME OF GOD Flagship Course on Health Sector Reform and Sustainable Financing; Module 4: : How to construct.
Citation Zajac, I. T., Duncan, A., Flight, I., Wilson, C., Wittert, G., & Turnbull, D (2015). The Relationship of Self-Rated Health and Health Priorities.
New and ongoing areas of research In the EuroQol Group.
University of Minnesota Medical Technology Evaluation and Market Research Department of Healthcare Management Course: MILI/PUBH 6589 Spring Semester, 2013.
Introduction Patients with tumors affecting the spine have significant impairments in Quality of Life domains that include physical function, neural function,
317_L26, Mar J. Schaafsma 1 Review of the Last Lecture Are looking at program evaluation in healthcare Three methods: CBA, CEA, CUA discussed CBA,
#1 STATISTICS 542 Intro to Clinical Trials Quality of Life Assessment.
Lecture 6: Reliability and validity of scales (cont) 1. In relation to scales, define the following terms: - Content validity - Criterion validity (concurrent.
1 The valuation of disease-specific health states to facilitate economic evaluation E. Kok, E. Stolk, Jan J. v. Busschbach Address: –Jan v. Busschbach.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 6: Cost-effectiveness analysis – Part.
Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D Viersprong Institute for studies on Personality Disorders (VISPD)
1 EQ-5D, HUI and SF-36 Of the shelf instruments…..
Patsi Sinnott, PT, PhD, MPH HERC Economics Course April 7, 2010 Introduction to Effectiveness, Patient Preferences and Utilities.
Economic evaluation of psychotherapy for personality disorders: burden of disease and cost-effectiveness Djøra Soeteman Viersprong Institute for Studies.
Overview of Health-Related Quality of Life Measures May 22, 2014 (1:00 – 2:00 PDT) Kaiser Methods Webinar Series 1 Ron D.Hays, Ph.D.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 23: Nov 17, 2008.
Sample Size Determination in Studies Where Health State Utility Assessments Are Compared Across Groups & Time Barbara H Hanusa 1,2 Christopher R H Hanusa.
Health-Related Quality of Life Preference Measures for Vision Studies Ron D. Hays, Ph.D. UCLA GIM & HSR June 10, 2009 (2:30-4:00 pm) Irvine, CA.
1 Health outcome valuation study in Thailand Sirinart Tongsiri Research degree student Health Services Research Unit, Public Health & Policy Department.
Using a Discrete Choice Experiment to Value the EQ-5D-5L in Canada Nick Bansback Assistant Professor School of Population and Public Health, University.
1 Interactive Introduction Cost Effectiveness and Psychotherapy Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren
Applying Expectancy-value Model to understand Health Preference An Exploratory Study Xu-Hao Zhang Department of Pharmacy National University of Singapore.
Hermann P. G. Schneider, Alastair H. MacLennan and David Feeny
T10 OUTCOME ASSESSMENT Why, what and how? Dr. Frederike van Wijck & John Dennis.
“Introduction to Patient Preference Methods used for QALYs” Presented by: Jan Busschbach, PhD, Chair Section Medical Psychology and Psychotherapy, Department.
Flagship Program on Health Sector Reform and Sustainable Financing.
T10 OUTCOME ASSESSMENT Why, what and how? Dr. Frederike van Wijck & John Dennis.
T10 OUTCOME ASSESSMENT Why, what and how? Dr. Frederike van Wijck & John Dennis.
Overlap between Subjective Well-being and Health-related Quality of Life. 3 Ron D. Hays, Ph.D. (Alina Palimaru) November 18, 2015 (11:30-12:00 noon) Geriatric.
1 Are values cultural determined…..  Many believe that QoL is cultural determined  One of the starting points of the EuroQol group.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 7: Cost-effectiveness analysis – Part.
PHARMAECONOMICS Pulmonary Arterial Hypertension Nelli ÄIJÖ & Feyza Nur POLAT Nika Marđetko.
LSE Summit Rethinking regulation and value assessment of medical technologies: challenges and opportunities Valentina Prevolnik Rupel, PhD Institute for.
Advancing Knowledge to Improve Health Evaluation of the Effects of Complex Care Management on Health-Related Quality of Life within a Medicaid Population.
Health Related Quality of Life after serious occupational injuries and long term disability Presenter: Ibishi Nazmie MD,PhD University Clinical Center.
Table 1. Characteristics of generic HRQOL assessments in adult physical activity research Peter D. Hart et al. Systematic Review of Health-Related Quality.
Global burden of diseases
Patient Baseline Assessment
The valuation of disease-specific questionnaires for QALY analysis
Measuring outcomes Emma Frew October 2012.
Elicitation methods Health care demands exceed resource supply
Presentation transcript:

Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 11: Cost-utility analysis – Part 4 Oct 8, 2008

Plan of class  Finish material from last class  Preference-based generic instruments  Construction of QALYs  Limitations of QALYs  QALYs vs DALYs

Preference-based generic instruments: Purpose  SG, TTO difficult and costly to use  One would prefer a simpler instrument  Administer to subjects in a study to evaluate their health-related quality of life as rated by a community sample

Preference-based generic instruments: 2 steps in use QUESTIONNAIRE THAT ASKS AT WHICH OF 3 TO 6 LEVELS RESPONDENT IS ON 5 TO 15 DIMENSIONS FORMULA FOR CONVERTING RESPONSES INTO A HEALTH RELATED QUALITY OF LIFE WEIGHT FROM 0 TO 1 (VALUE OR UTILITY DEPENDING ON QUESTIONNAIRE)

Questionnaire design  Obvious differences:  Number and choice of dimensions  Number of levels for each dimension

InstrumentDimensionsNumber of levels per dimension Number of states Quality of well-being Mobility, physical activity, social functioning 27 symptoms/problems EQ-5DMobility, self-care, usual activities, pain/dicscomfort, anxiety/depression 3243 SF-6DPhysical functioning, role limitation, social functioning, pain, energy, mental health 4 – 618,000 (SF-36) 7,500 (SF-12) HUI2Sensory, mobility, emotion, cognitive, self- care, pain Fertility 4 – ,000 HUI3Vision, hearing, speech, ambulation, dexterity, emotion, cognition, pain 5 – 6972,000 Note: At least two other questionnaires exist: Australian Quality of Life (AQoL) and the Finnish 15D. Not as widely used as EQ-5D, SF-6D or HUI2 or HUI3. Not discussed in class.

Rheumatism Pain/ Dexterity Macular degene- ration Vision Limits Walking Limits ability to read Role, social and usual activities Disease or disorder ImpairmentAbilityParticipation WHO international classification of health into disease or disorder, impairment, ability and participation (with examples). (Taken from Brazier et al., Measuring and valuing health benefits for economic evaluation, Oxford, 2007, Fig 4.1 ) Health as a spectrum

Rheumatism Pain/ Dexterity Macular degene- ration Vision Limits Walking Limits ability to read Role, social and usual activities Disease or disorder ImpairmentAbilityParticipation HUI3 SF-6D, EQ-5D, HUI2

Include dimensions relating to social participation?  “Within skin” aspects of health: avoid measuring peoples’ choices/preferences  “purer” measure of health  No influence of adaptation  But general population values will underestimate adaptation  Health is a means, social participation part of its end – this is what matters to patients

InstrumentCountry where preferences obtained Valuation technique Quality of well-being USA (San Diego)VAS EQ-5DBelgium, Denmark, Finland, Germany, Japan, The Netherlands, Slovenia, Spain, UK, USA, Zimbabwe TTO, VAS, ranking SF-6DHong Kong, Japan, UK, Australia, Brazil SG, ranking HUI2Canada (Hamilton), UKVAS transformed into SG HUI3Canada (Hamilton), FranceVAS transformed into SG

Scoring the questionnaires  In each case, use a method such as SG, TTO, VAS to value some states, and interpolate statistically  Too many states to value them all individually!  Two approaches to developing scoring methods:  Multi-attribute utility theory (MAUT): HUI2, HUI3  Statistical estimation without restrictive assumptions of MAUT: QWB, SF-6D, EQ-5D

Multi-attribute utility theory: The problem  What happens when lottery outcome yields something that has several attributes, such as mobility, emotional state, etc?  How to combine the utilities of separate dimensions of outcome to generate an overall utility of the outcome?

Example  How would you combine utilities derived from an apartment that you might rent? Attributes include: (a) price; (b) location; (c) size; (d) quietness; (e) attractiveness; (f) other factors.

3 most common methods based on MAUT  In all cases, need to calculate utility associated with each dimension  Additive, multiplicative, multilinear (see formulas in book, p. 157)  The simpler the method, the more restrictive the assumptions  e.g., additive implies no interactions  HUI2 and HUI3 use multiplicative formula

Exercises  On the EQ-5D, considering Table 6.4, what does score mean? What health-related quality of life weight does this represent?  On the HUI3, same questions for

Choice of instrument matters  Different instruments yield different results  Different ranges: -0.4 to 1.0 for EQ-5D, vs. 0.3 to 1.0 for SF-6D  EQ-5D scores of can translate to SF-6D scores as low as 0.56  Studies comparing scores across instruments for same patients find significant differences Patient group appears to be a factor  Differences as small as 0.03 should be considered significant

Reasons for differences  Differences in coverage  Capacity vs functioning  Symptoms, social health, mental health covered differently  Sensitivity of dimensions  Floor effect for physical and social functioning, role limitations for SF-6D  Ceiling effect with EQ-5D  Valuation methods  Systematic differences depending on method

Choosing a method: Practicality InstrumentComments on practicality – self-administered Quality of well-beingSomewhat more complex to fill out EQ-5DEasiest to administer, very simple SF-6DUsually derived from responses to SF-36 or SF-12 which are longer, lower completion rates HUI2Easy to administer, license costs HUI3Easy to administer, license costs

Choosing a method: Reliability  All have acceptable test-retest reliability  Different responses depending on whether patients or health professionals fill out – need to standardize to whom instrument administered

Choosing a method: Validity  QWB based on VAS  HUI2 and HUI3 based on SG but as transformation of VAS; not clear this is better than TTO used in EQ-5D  Populations from which data for scoring formulas derived are more or less comprehensive – more limited for HUIs, very broad for EQ-5D  Unclear how important this is

Choosing a method: Conclusions  Differences in dimensions covered, number of levels, floor and ceiling effects may make one of the instruments more suitable for a particular patient group  Which would you use for assessing cataract surgery? Antidepressants?  Use HUI3 rather than HUI2  Don’t use QWB

A QALY exercise  With new cancer protocol: 6 months at HRQOL 0.3, followed by 15 years at 0.95  With standard treatment: 1 year at 0.5, followed by 7 years at 0.90, then 1 year at 0.8, 1 year at 0.5, then death  How many QALYs does the new protocol produce?

Limitations of QALYs (partial list)  Ignore priority often given to helping people at low initial state  Many small improvements to people at high initial state can be preferred to saving a life  Imperfectly measured  Use anyway?

QALYs vs DALYs (Disability- adjusted life years) FeatureQALYsDALYs Life expectancy measureContext-specificLongest in world (Japanese women) Disability weightsPreferences (public or patients in study) PTO scores from a panel of health care workers PrecisionContinuous scores7 states in addition to healthy or dead Age weights?NoYes – lower weights for young and elderly DALYs developed to do estimate potential impacts of possible health interventions in developing countries